36C24227D0008_1.docx

This is an Award Notice for cytopathology and next generation sequencing (NGS) testing services. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded contract 36C24227D0008 to Laboratory Corporation of America (LabCorp) for a total contract value of $1,334,700.00, with an award date of October 1, 2026. The contract was issued under solicitation number 36C24226Q0875 and is designated as Q301, indicating it falls under a specific contracting vehicle or schedule agreement with the VA healthcare system.

The contract encompasses cytopathology testing services, which involve microscopic examination of cellular samples, and next generation sequencing testing services, which provide advanced genetic and molecular analysis capabilities. These laboratory services support the VA's clinical diagnostics and patient care requirements across the Veterans Integrated Service Network 2. As the sole awardee under this solicitation, LabCorp will serve as the primary laboratory service provider for these specialized testing capabilities within the designated VA healthcare network.